Regeneron Co-Chief Scientific Officer Andrew J. Murphy reports $12.9 million disposal of common shares
REGN•Andrew J. Murphy sold 4,147 Regeneron common shares on October 14, 2026, after disposing of 12,853 shares at $754.58 each the previous day. He also exercised options for 17,000 shares at $381.92 each on October 13.
1. Share transactions
Regeneron Pharmaceuticals Co-Chief Scientific Officer Andrew J. Murphy sold 4,147 common shares on October 14, 2026. On October 13, he exercised non-qualified stock options for 17,000 shares at $381.92 each and disposed of 12,853 shares at $754.58 each. After the transactions, he held 47,833 shares directly and another 4,414 indirectly through a 401(k) plan.
